HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY High River v. Mylan Labs. | Secondary Sources | Westlaw

HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY High River v. Mylan Labs. | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY High River v. Mylan Labs., Secondary Sources
Skip Page Header

HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY High River v. Mylan Labs.

11 No. 7 ANDERLR 5Andrews Derivatives Litigation Reporter (Approx. 3 pages)

HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY High River v. Mylan Labs.

11 No. 7 ANDERLR 5Andrews Derivatives Litigation Reporter (Approx. 3 pages)

11 No. 7 Andrews Derivatives Litig. Rep. 5
Andrews Derivatives Litigation Reporter
*1 February 18, 2005
Hedge Funds
Copyright © 2005 Thomson/West .

HEDGE FUND BATTLE OVER PHARMACEUTICAL MERGER MOVES TO NY

High River v. Mylan Labs.

A federal judge in Harrisburg, Pa., has ruled that a dispute between New York hedge funds over a proposed corporate merger involving Pennsylvania-based generic drug maker Mylan Laboratories Inc. belongs in Manhattan federal court.
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.